News & Press Releases
Filter by:
Mintz Advises on Protara Therapeutics' $75 Million Public Offering
December 16, 2025
Beyond Traditional IP: A Comprehensive AI Strategy for Life Sciences
December 16, 2025
Life Sciences Intellectual Property Review published an article by Member Terri Shieh‑Newton offering guidance on how life sciences companies should build a modern IP strategy that accounts for AI‑driven, data‑centric innovation.
Mintz Advises on Fulcrum Therapeutics' $175 Million Public Offering
December 16, 2025
Mintz advised the underwriters in connection with Fulcrum Therapeutics' $175 million public offering.
Mintz advised Cultivo, a leading platform for developing and operating natural assets at scale, on its acquisition of leading carbon grasslands project developer Kateri.
Mintz Advises on Wave Life Sciences $402.5 Million Public Offering
December 12, 2025
Mintz advised Wave Life Sciences in its $402.5 million public offering.
Mintz Advises on Capricor Therapeutics’ $150 Million Public Offering
December 10, 2025
Mintz advised the underwriters in connection with Capricor Therapeutics’ $150 million public offering.
